Inflammation and CSC Activation

Chronic inflammation plays a significant role in cancer initiation and progression, often leading to the activation of cancer stem cells (CSCs). This track investigates the links between inflammatory signaling pathways—such as NF-κB, IL-6, and TNF-α—and the activation of CSCs. Researchers explore how inflammation within the tumor microenvironment promotes CSC self-renewal, survival, and metastasis. Targeting the inflammatory signals that support CSCs could lead to novel therapeutic strategies that disrupt this relationship, limiting tumor growth and progression. This research highlights the importance of anti-inflammatory agents in cancer treatment, offering new opportunities to inhibit CSC-driven malignancies by reducing inflammation.

    Related Conference of Inflammation and CSC Activation

    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 26-27, 2025

    15th World Congress on Breast Cancer

    Rome, Italy
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 13-14, 2025

    8th International Conference on Anti-Cancer Drugs & Therapies

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain

    Inflammation and CSC Activation Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in